Is it safe to co-administer trazodone with gabapentin?

Can Trazodone Be Used With Gabapentin?

Yes, trazodone can be safely co-administered with gabapentin, and this combination is commonly used in clinical practice. There are no contraindications or significant drug-drug interactions between these two medications.

Evidence Supporting Co-Administration

The FDA drug label for trazodone does not list gabapentin as a contraindicated medication or as having any significant pharmacokinetic interactions 1. Importantly, gabapentin has few drug interactions and does not significantly affect the metabolism of other medications 2.

Pharmacokinetic Data

A dedicated pharmacokinetic study specifically investigated potential drug-drug interactions between trazodone and gabapentin at a fixed-dose combination of 10/100 mg 3. This study confirmed the absence of pharmacokinetic interaction when comparing the combination versus individual agents, demonstrating that neither drug significantly alters the plasma concentrations or bioavailability of the other.

Clinical Evidence

A randomized controlled trial evaluated the combination of low-dose trazodone (10-20 mg three times daily) with gabapentin as background therapy in 141 patients with painful diabetic neuropathy 4. The study demonstrated:

• The combination was well-tolerated with no serious adverse events
• 62.8% of patients achieved ≥50% pain reduction with trazodone 30 mg/day plus gabapentin
• Most frequent adverse events were nervous system effects, QT prolongation, and gastrointestinal disorders—consistent with the known side effect profiles of each drug individually

Important Safety Considerations

While the combination is safe, you must monitor for additive CNS depression effects:

• Both medications cause dose-dependent dizziness and sedation 2
• Start with lower doses of each medication and titrate cautiously
• Warn patients about increased drowsiness, especially when initiating therapy or increasing doses
• Advise caution with activities requiring alertness (driving, operating machinery)

Cardiac Monitoring

Trazodone carries specific cardiac risks that require attention regardless of gabapentin co-administration 1:

• Trazodone prolongs the QT/QTc interval and can cause cardiac arrhythmias
• Avoid in patients with known QT prolongation or cardiac arrhythmias
• Use with caution in patients with cardiac disease
• Consider baseline ECG in patients >40 years old or with cardiac risk factors

Dosing Approach

When combining these medications:

For Gabapentin 2:

• Start: 100-300 mg at bedtime or three times daily
• Titrate: Increase by 100-300 mg every 1-7 days as tolerated
• Target: 1800-3600 mg/day in divided doses
• Adjust for renal insufficiency

For Trazodone 1:

• Start: 25-50 mg at bedtime (lower than the FDA-recommended 150 mg/day for depression)
• Titrate: Increase by 25-50 mg every 3-7 days as tolerated
• Monitor for excessive sedation when combined with gabapentin

Common Pitfalls to Avoid

1. Don't overlook additive sedation: The combination produces more sedation than either drug alone—this is predictable and manageable with dose adjustment
2. Don't forget renal dosing for gabapentin: Always adjust gabapentin dose based on creatinine clearance
3. Don't ignore cardiac history: Screen for cardiac disease before initiating trazodone, regardless of gabapentin use
4. Don't abruptly discontinue: Both medications should be tapered gradually to avoid withdrawal symptoms 1

The combination of trazodone and gabapentin is pharmacologically compatible and clinically useful, particularly for neuropathic pain conditions, but requires monitoring for additive CNS depression and attention to trazodone's cardiac effects.